Wire Stories

NICE Wins 2022 Best Practices Award for Technology Innovation Leadership in Asia-Pacific Market

Frost & Sullivan recognizes NICE for its industry-leading solutions that deliver efficient and smart AI-powered…

Ubiquitome gets FDA authorization with Yale SARS-CoV-2 self-collection tests

NIH RADx winner’s next gen Liberty16 Pro gets EUA AUCKLAND, New Zealand--(BUSINESS WIRE)--#COVIDCATCHER--Ubiquitome’s next generation…

Kyocera Plans New Manufacturing Plant in Japan’s Nagasaki Prefecture by 2026

Company envisions up to 1,000 jobs in Isahaya City as other sites near full capacity…

Dr. Reddy’s Successfully Completes Phase 1 Study of DRL_TC, a Proposed Biosimilar of Tocilizumab

Tocilizumab is an important anti-rheumatic agent used in the treatment of adult patients with moderate…

Introducing THE BRIJ – A World of Arts and Culture

Serendipity Arts announces THE BRIJ, a futuristic arts and culture centre in the National Capital…

Movers Buddy Reports Affordable Suburbs To Move To If You Want To Save On Rent In Melbourne And Sydney

MELBOURNE, Australia--(BUSINESS WIRE)--As rents continue to soar, Australian families are struggling more than ever before…

Dongying seeks trade opportunities in overseas markets

DONGYING, China--(BUSINESS WIRE)--Dongying, a city in East China’s Shandong province, has been helping local enterprises…

A Third of Businesses Predict the Current Inflationary Environment to Last More Than Two Years – Taulia

SAN FRANCISCO--(BUSINESS WIRE)--A third of global businesses predict the current inflationary environment to continue for…

ENHERTU® Recommended for Approval in the EU by CHMP for Patients with HER2 Low Metastatic Breast Cancer

Daiichi Sankyo and AstraZeneca’s ENHERTU is the first HER2 directed therapy to demonstrate a significant…

ENHERTU® Approved in the EU for Patients with Previously Treated HER2 Positive Advanced Gastric Cancer

First HER2 directed medicine to be approved for gastric cancer in the EU in more…